Drug intelligence / Profile preview

Dahuangling Pi Formula

Development stage
Unknown
Lead developer
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Administration
Oral
01

Overview

Dahuangling Pi Formula is a Traditional Chinese Medicine (TCM) herbal decoction primarily composed of *Rheum palmatum* (Dahuang) and *Epimedium* (Lingpi/Xianlingpi). Developed by the Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine at the Shanghai University of Traditional Chinese Medicine, the formula is designed to prevent the progression of acute kidney injury (AKI) to chronic kidney disease (CKD). It operates on the TCM principle of "tonifying the kidney and removing turbidity." The active components, such as rhein from Rhubarb and icariin from Epimedium, are believed to exert renoprotective effects by promoting the excretion of nitrogenous waste, inhibiting renal fibrosis, and modulating inflammatory and oxidative stress pathways.

Other names
Modified Dahuangling Pi FormulaDahuang Lingpi FangDahuang Lingpi Decoction
02

Targets

NF-κBTGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on Dahuangling Pi Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dahuangling Pi Formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call